Market Risers: Nanoco Group PLC, AstraZeneca plc, Centrica PLC, Aviva plc, Legal & General Group Plc & Prudential plc

Nanoco Group PLC
[shareaholic app="share_buttons" id_name="post_below_content"]

Shares of Nanoco Group PLC with company EPIC: LON:NANO has gained 4.32% or 2.27 points during the course of today’s session so far. Buyers are a positive bunch during this period. The periods high figure was 55 and hitting a low of 53.5. The total volume traded so far comes to 294,379 while the daily average number of shares exchanged is 431,217. The 52 week high for the share price is 55 about 2.4 points in difference to the previous days close of business and a 52 week low sitting at 30.3 is a variance of 22.3 points. Nanoco Group PLC has a 20 day moving average of 49.97 and the 50 day moving average now of 45.06. The market capitalisation currently stands at £156.90m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for Nanoco Group PLC being recorded at Friday, February 22, 2019 at 11:52:21 AM GMT with the stock price trading at 54.87 GBX.

 

The share price for AstraZeneca plc EPIC code: LON:AZN has stepped up 1.16% or 71 points during today’s session so far. Traders have remained positive during the session. The high for the period has peaked at 6168.37 dipping to 6081. Volume total for shares traded at this point reached 362,486 with the daily average number around 2,623,134. A 52 week high for the stock is 6432.48 some 336.48 points different to the previous business close and a 52 week low sitting at 4710.5 making a difference of 1385.5 points. AstraZeneca plc now has a 20 simple moving average of 5793.95 and now the 50 day moving average at 5841.11. The market capitalisation is now £78,142.15m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Friday, February 22, 2019 at 11:59:59 AM GMT with the stock price trading at 6167 GBX.

 

The stock price for Centrica PLC with company EPIC: LON:CNA has increased 1.24% or 1.5 points throughout the session so far. Traders have remained positive throughout the session. The period high was 122.7 and a low of 117.05. The number of shares traded by this point in time totalled 10,568,389 while the daily average number of shares exchanged is 24,297,804. A 52 week high for the stock is 164.5 equating to 43.35 points difference from the previous close and the 52 week low at 117.05 which is a difference of 4.10 points. Centrica PLC has a 20 day moving average of 138.42 and a 50 day moving average at 137.09. The market capitalisation is now £6,987.23m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for Centrica PLC being recorded at Friday, February 22, 2019 at 11:59:59 AM GMT with the stock price trading at 122.65 GBX.

 

The trading price for Aviva plc found using EPIC: LON:AV has risen 1.54% or 6.5 points during today’s session so far. Buyers have remained positive during the session. The periods high has reached 429.3 meanwhile the session low reached 421.5. The total volume of shares traded by this point was 1,217,153 while the average shares exchanged is 8,902,780. The 52 week high for the shares is 554.6 amounting to 132.6 points difference from the previous close and the 52 week low at 361.8 which is a variance of 60.2 points. Aviva plc now has a 20 SMA of 423.38 and also a 50 day MA at 405.43. The market capitalisation is now £16,723.56m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Aviva plc being recorded at Friday, February 22, 2019 at 12:03:19 PM GMT with the stock price trading at 428.5 GBX.

 

Shares of Legal & General Group Plc ticker lookup code: LON:LGEN has moved up 1.22% or 3.3 points throughout today’s trading session so far. Investors have remained positive during the trading session. The periods high has reached 274.4 and hitting a low of 270.7. The total volume of shares exchanged through this period comes to 1,630,475 with the daily average at 13,276,062. The stock 52 week high is 289.45 some 18.85 points in difference to the previous days close of business and a 52 week low sitting at 221.8 is a variance of 48.8 points. Legal & General Group Plc has a 20 day moving average of 265.84 with a 50 day moving average now at 251.56. The current market cap is £16,326.67m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Legal & General Group Plc being recorded at Friday, February 22, 2019 at 12:02:40 PM GMT with the stock price trading at 273.9 GBX.

 

Shares of Prudential plc EPIC code: LON:PRU has gained 1.08% or 16.5 points throughout the session so far. Investors have remained optimistic while the stock has been in play. The periods high figure was 1551 while the low for the session was 1529.5. The total volume of shares exchanged through this period comes to 708,486 whilst the daily average number of shares exchanged is just 4,501,161. The 52 week high is 1962 about 432 points difference from the previous days close and the 52 week low at 1324.99 is a variance of 205.01 points. The market capitalisation is now £40,102.79m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Prudential plc being recorded at Friday, February 22, 2019 at 12:03:17 PM GMT with the stock price trading at 1546.5 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Nanoco Group plc unveils its 2024 preliminary results, highlighting a strategic shift towards value creation, leadership changes, and a 40% revenue boost.
AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.
AstraZeneca and Amgen's Tezspire shows promise in reducing nasal polyp size and congestion, offering hope for chronic rhinosinusitis patients.
Nanoco Group plc appoints Dmitry Shashkov as CEO, leveraging his 20 years of tech leadership to drive growth and strategic transformation.
AstraZeneca's Wainzua gains CHMP backing for EU approval in treating ATTRv-PN, marking a potential breakthrough with self-administered therapy.

Search

Search